Literature DB >> 9622503

Bimodal inhibition of caspase-1 by aryloxymethyl and acyloxymethyl ketones.

K D Brady1.   

Abstract

The caspase-1 (interleukin 1beta-converting enzyme; ICE) titrant 3-[2-(2-benzyloxycarbonylamino-3-methylbutyrylamino) propionylamino]-4 -oxo-5-(2-oxo-2H-chromen-7-yloxy)pentanoic acid (1 (Dang, L. C., et al. (1996) Biochemistry 35, 14910-14916)) inhibits caspase-1 activity rapidly, while release of the 7-hydroxycoumarin fluorophore is much slower. Progress curve analysis of 1 and of the related acyloxymethyl ketone 3-[2-(2-benzyloxycarbonylamino-3-methylbutyrylamino) propionylamino]-4 -oxo-5-(1-oxo-3-phenylpropoxy)pentanoic acid (2) identifies distinctive residual patterns which are caused by the superimposition of potent slow-binding reversible inhibition with slower, irreversible inactivation. Standard kinetic models are not entirely adequate for analysis of these bimodal inhibitors, but by measuring the kinetic properties of these inhibitors by several independent techniques and comparing these to simulations which closely mimic the inhibitor actions, careful application of the standard models can provide reasonably accurate kinetic constants.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622503     DOI: 10.1021/bi9803325

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

2.  Caspase selective reagents for diagnosing apoptotic mechanisms.

Authors:  Marcin Poreba; Katarzyna Groborz; Mario Navarro; Scott J Snipas; Marcin Drag; Guy S Salvesen
Journal:  Cell Death Differ       Date:  2018-05-10       Impact factor: 15.828

3.  Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.

Authors:  M S Head; M D Ryan; D Lee; Y Feng; C A Janson; N O Concha; P M Keller; W E deWolf
Journal:  J Comput Aided Mol Des       Date:  2001-12       Impact factor: 3.686

4.  Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.

Authors:  Katrien Brak; Iain D Kerr; Kimberly T Barrett; Nobuhiro Fuchi; Moumita Debnath; Kenny Ang; Juan C Engel; James H McKerrow; Patricia S Doyle; Linda S Brinen; Jonathan A Ellman
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

5.  Identification of a new class of nonpeptidic inhibitors of cruzain.

Authors:  Katrien Brak; Patricia S Doyle; James H McKerrow; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2008-04-25       Impact factor: 15.419

6.  Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.

Authors:  Maria A Argiriadi; Tao Xiang; Chengbin Wu; Tariq Ghayur; David W Borhani
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

Review 7.  Caspase substrates and inhibitors.

Authors:  Marcin Poreba; Aleksandra Strózyk; Guy S Salvesen; Marcin Drag
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

8.  Azanitrile Inhibitors of the SmCB1 Protease Target Are Lethal to Schistosoma mansoni: Structural and Mechanistic Insights into Chemotype Reactivity.

Authors:  Adéla Jílková; Martin Horn; Jindřich Fanfrlík; Jim Küppers; Petr Pachl; Pavlína Řezáčová; Martin Lepšík; Pavla Fajtová; Petra Rubešová; Marta Chanová; Conor R Caffrey; Michael Gütschow; Michael Mareš
Journal:  ACS Infect Dis       Date:  2020-12-10       Impact factor: 5.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.